McKesson’s $8 bln Celesio bid falls a bit short
Celesio ma non troppo
U.S. pharmaceutical wholesaler McKesson has struck a deal with Celesio’s owner to buy the German group in a 6.1 billion euro deal. But the 39 percent premium it implies still leaves the offer on the lower end of what minorities could expect. There may be room for more.
This content is for Subscribers only
To access full Breakingviews.com content you must be a subscriber. Please use the following link to request a trial.